España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Isracann Biosciences
ISCNF
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.000001
0.00
0.00%
Pre-Market: Nov 26, 4:08 PM EDT
Get Report
Comment
Isracann Biosciences (ISCNF) Forecast
News
Earnings
Isracann Biosciences (ISCNF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Isracann Biosciences (OTC:ISCNF) Stock
Isracann Biosciences Stock (OTC: ISCNF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, September 28, 2022
Isracann Bioscience Facilitated High THC Cannabis Genetics Arrive In Israel
Vuk Zdinjak
Wednesday, September 14, 2022
Isracann Bioscience Facilitates Cannabis Genetics Shipment To Israel
Vuk Zdinjak
Thursday, September 01, 2022
Isracann's Praesidio Expands Its Natural Health Products Distribution Network: Inks Deal With Pure Integrative Pharmacy
Vuk Zdinjak
Thursday, August 25, 2022
US Cannabis Council & Other Marijuana Players Just Made Some Key Executive Changes You Should Know About
Jelena Martinovic
Wednesday, August 03, 2022
Cannabis Company Isracann Biosciences Raises $234K In The First Tranche Of Private Placement
Vuk Zdinjak
Thursday, May 19, 2022
Isracann Biosciences' Subsidiary Praesidio Health Submits NPNs To Health Canada
Vuk Zdinjak
Thursday, April 14, 2022
Isracann Biosciences Acquires Praesidio Health And Appoints Natural Health Products Officers
Vuk Zdinjak
Monday, March 28, 2022
Isracann Biosciences Signs Definitive Agreement To Acquire Praesidio Health For $3.18M
Vuk Zdinjak
Wednesday, February 23, 2022
Isracann To Acquire Natural Health Medicine Developer Praesidio Health For $3.14M
Vuk Zdinjak
Monday, October 25, 2021
Cannabis Movers & Shakers: Urban-Gro, MediPharm Labs, RWB, Isracann Biosciences, MedMen
Jelena Martinovic
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Friday, January 03, 2020
The Week In Cannabis: Illinois Goes Rec, Quebec Pulls Back And A Recap Of 2019
Javier Hasse
Isracann Signs Preliminary Deal For European Cannabis Distribution
Nina Zdinjak
